Clinical Trial

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-04-09; most recent amendment 2026-03-09.
Status change: Not Yet Recruiting → Recruiting 2019-10-25
Trial Details
NCT Number NCT03912194
Lead Sponsor University of Alabama at Birmingham
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Tobacco Dependence
Enrollment 400 participants
Start Date 2019-08-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-11